Searchable abstracts of presentations at key conferences in endocrinology

ea0011oc23 | Clinical endocrinology | ECE2006

Improved Prognosis in Midgut Carcinoid patients by treating raised circulating Neurokinin A (NKA)

Ardill JES , Johnston BJ , Turner GB , McGinty A , McCance DR

Midgut Carcinoid disease (MGC) is uncommon, occurring in approximately 1.4 per 100,000 of the population per year. MGC has an unpredictable disease progression varying from rapid and aggressive to slow and indolent. For this reason it is not appropriate to treat all patients according to the same schedule. As some treatments are not without risk, it is important to identify those patients selected for these options at an appropriate stage of disease.In a...